Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
Abroad (travel likely)Recruiting
Conditions
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
Contact: Study coordinator (Marc G Pawlitzki, PD Dr. med.) · neuro-trials@med.uni-duesseldorf.de · +49 02118117887University Hospital Münster, Münster, North Rhine-Westphalia, Germany
Contact: Study coordinator (Matthias Schilling, Prof. Dr. med.) · matthias.schilling@-ukmuenster.-de · +49 251 83-48199
Study leads
Marc G Pawlitzki, PD Dr. med.
Principal Investigator
Department of Neurology, Heinrich-Heine University, and University Hospital Duesseldorf, Germany